skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))

Preferred term

n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • 0

formula

  • C65H112N3O37R

mass

  • 1527.585

monoisotopicmass

  • 1526.69747

smiles

  • O[C@H]1[C@H](O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](O)[C@H]([C@H](O[C@@H]4[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]4O)O)CO)O[C@@H]3CO)O)O[C@H](CO)[C@@H]2O)NC(C)=O)[C@@H]([C@H]1O[C@H]5O[C@@H]([C@@H]([C@@H]([C@H]5O)O[C@H]6[C@@H]([C@H]([C@@H](O)[C@H](O6)CO)O)NC(C)=O)O)CO)O[C@@H]7O[C@H]([C@H]([C@H]([C@@H]7O)O)O)C)CO

subset

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142148

Download this concept: